C-Arms Market By Type (Mobile C-Arms, Fixed C-Arms), By Application (Cardiology, Gastroenterology, Neurology, Orthopedic and Trauma, Oncology, Others), By End User (Hospitals, Diagnostic Centers, Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031

C-Arms Market

C-arms is an advanced imaging technology based on the principles of X-ray technology. It is increasingly being used in well-equipped hospitals, diagnostic centers and clinics. In addition, this technique is increasingly being used in minimally invasive surgical procedures. These are also known to intensify the image which in turn results in diagnostic and treatment purposes. C-arms comprises a generator called X-Ray source and an image intensifier for a flat panel detector. It is often used in surgery, orthopedics, traumatology, vascular surgery and cardiology for intra-operative imaging. The device provides high-resolution X-ray images in real time, allowing the surgeon to monitor progress at any point during the surgery.   

Key factors driving the growth of the C-arms market include the increase in the prevalence of chronic disease, increase in the number of surgical procedures and Rise in technological advancement. The prevalence of chronic diseases is increasing due to lifestyle changes and rising industrialization. The high prevalence of chronic diseases such as heart diseases, diabetes, cardiovascular disease, chronic respiratory diseases, and others cause mortality and morbidity across the world is expected to increase the demand for medical imaging procedures to diagnose and treat such diseases, which, in turn, is expected to create a high demand for C-arms devices that propels the growth of the market. For instance, according to the report published by World Health Organization in September 2022, noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally. Each year, 17 million people die from NCD before age 70; 86% of these premature deaths occur in low- and middle-income countries of all NCD deaths, 77% are in low- and middle-income countries. In addition, cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes). Furthermore, C-arms devices allow doctors to get a detailed image of the patient’s body and diagnose and treat the condition more effectively. Thus, with the increasing prevalence of chronic diseases, the demand for C-arms devices is also increasing, driving the growth of the C-arms market. 

The rise in technological advancements in C-arms, such as improved imaging resolution and image intensifier tubes, are expected to fuel the demand for C-arms. These advancements have enabled C-arms to be used for a variety of purposes, including vascular surgeries, orthopedic surgeries, and tumor treatment. For instance, in June 2022, Siemens AG, launched its new, ceiling-mounted Artis icono ceiling angiography system. It provides three-dimensional (3D) data both at the patient’s head and from the patient’s side over a complete angular range of 200 degrees. Thus, increase in the number of R&D activities for the development of, technological advanced C-arms devices has allowed for improved image archiving and communication, that allows doctors to easily share images and collaborate with other medical professionals. 

The market also offers growth opportunities to the key players in the market. The rise in prevalence of chronic disease and growing preference for minimally invasive surgeries in developing nations (such as Brazil, India, and China) will increase the demand for technologically advanced diagnostic devices that is anticipated to provide lucrative growth opportunities for the market. For instance, according to the report published Centre for Disease Control and Prevention, in February 2023, it has been estimated that, six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America, and they are also a leading driver of health care costs. Moreover, the rising awareness about the benefits of C-arms and the increasing availability of advanced medical care in emerging countries are expected to drive the growth of the C-arms market. Additionally, the presence of a large number of untapped opportunities in the emerging markets and the surge in geriatric populations is expected to propel the growth of the C-arms market in the upcoming years. Furthermore, the emerging nations need to focus on the adoption of the latest technologies for C-arms that are crucial to diagnose and treat various chronic disorders. Thus, as healthcare services become more accessible, medical practitioners are turning to more sophisticated imaging technologies such as C-arms to diagnose and treat diseases that offer lucrative opportunities for the growth of the C-arms market during forecast period. 

The C-arms market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into mobile C-arms and fixed C-arms. By type, the mobile C-arms is further bifurcated into mini-C-arms and full-sized C-arms. On the basis of application, it is classified into cardiology, gastroenterology, neurology, orthopedics and trauma, oncology, and others. By end user, it is segmented into hospitals, diagnostic centers, and specialty clinics. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.  

The key players that operate in the C-arms market are Canon Inc, Fujifilm Holding Corporation, General Electric Company, Hologic Inc, Koninklijke Philips N.V., Nanjing Perlove Medical Equipment Co. Ltd., Shimadzu Corporation, Siemens AG, Trivitron Healthcare and Ziehm Imaging GmbH. 

Key Market Insights 

By type, the mobile C-arms segment is expected to experience rapid growth in the market and is estimated to reach $ 1,704.45 million by 2031, with a CAGR of 5.2%. However, the fixed C-arms segment is estimated to be growing with a significant CAGR of 4.6% during the forecast period. 

By application, the orthopedic & trauma segment dominated the global market. However, the neurology segment is expected to grow with a significant CAGR of 6.8% during the forecast period. 

By end user, the hospitals segment dominated the global market. However, the diagnostics segment is expected to grow with a significant CAGR of 5.1% during the forecast period. 

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 6.3% during the forecast period. 

 

Overview

The global c-arms market was valued at $2,003.12 million in 2021 and is projected to reach $3,233.76 million by 2031, registering a CAGR of 4.9% from 2022 to 2031. A C-arm machine is an advanced medical imaging device based on X-ray technology. They are primarily used for their fluoroscopy capabilities, although they have radiography capabilities too. The C-arm is called so due to its C-shaped arm, which is used to connect the x-ray source on one end and the detector on the other. It is a type of medical imaging device that is most commonly used in orthopedics, pain management, and vascular procedures. It is a type of x-ray device that is mobile and can be wheeled around the operating room. The C-arm is an imaging device that takes a series of x-ray images of the area of interest. It is used to visualize bones, soft tissue, and blood vessels.    

The key factor that drives the growth of the C-arms market is the rise in the prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders, increase in the number of bone injuries and a growing geriatric population are the major factors driving the growth of the market. In addition, chronic diseases are the leading cause of death and disability worldwide, and their prevalence is increasing due to lifestyle changes, an ageing population, and unhealthy diets. For instance, according to the Centers for Disease Control and Prevention (CDC), an estimated 117 million U.S. adults (47.4%) had at least one chronic health condition as of 2021. The most prevalent chronic diseases are heart disease (affecting 45.8 million people), arthritis (affecting 43.4 million people), diabetes (affecting 34.2 million people), high blood pressure (affecting 33.5 million people), cancer (affecting 13.7 million people), chronic lung disease (affecting 12.7 million people), and various others such as asthma, stroke, kidney disease, and Alzheimer's disease. Thus, the increase in the number of surgical procedures, and the rise in technological advancement in C-arms devices are anticipated to boost the growth of the market.    

However, C-arms are expensive medical imaging systems, and the cost of installation, maintenance, and repair can be high. This makes them inaccessible to many hospitals and imaging centers, which restrains market growth. Conversely, the rise in the prevalence of chronic disease and increase in demand for imaging technologies from emerging economies may open new market potential for C-arms and are expected to provide a lucrative opportunity for the growth of the market during the forecast period. 

The C-arms market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into mobile C-arms and fixed C-arms. The mobile C-arms is further bifurcated into mini-C-arms and full-sized C-arms. By type, the mobile C-arms is further bifurcated into mini-C-arms and full-sized C-arms. On the basis of application, it is classified into cardiology, gastroenterology, neurology, orthopedics and trauma, oncology, and others. By end user, it is segmented into hospitals, diagnostic centers, and specialty clinics. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.    

The key players that operate in the C-arms market are Canon Inc, Fujifilm Holding Corporation, General Electric Company, Hologic Inc, Koninklijke Philips N.V., Nanjing Perlove Medical Equipment Co. Ltd., Shimadzu Corporation, Siemens AG, Trivitron Healthcare and Ziehm Imaging GmbH. 

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the c-arms market analysis from 2021 to 2031 to identify the prevailing c-arms market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the c-arms market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global c-arms market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Canon Inc

Scope of C-Arms Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the prevalence of chronic disease

3.4.1.2. Increase in the number of surgical procedures

3.4.1.3. Rise in technological advancement

3.4.2. Restraints

3.4.2.1. High cost of C-arm devices

3.4.2.2. Lack of skilled professionals

3.4.3. Opportunities

3.4.3.1. High growth potential in developing economies

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Mobile C-Arms

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.2.4. Mobile C-Arms C-Arms Market by Type

4.3. Fixed C-Arms

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Cardiology

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Gastroenterology

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Neurology

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

5.5. Orthopedic and Trauma

5.5.1. Key market trends, growth factors and opportunities

5.5.2. Market size and forecast, by region

5.5.3. Market share analysis by country

5.6. Oncology

5.6.1. Key market trends, growth factors and opportunities

5.6.2. Market size and forecast, by region

5.6.3. Market share analysis by country

5.7. Others

5.7.1. Key market trends, growth factors and opportunities

5.7.2. Market size and forecast, by region

5.7.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Diagnostic Centers

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Specialty Clinics

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Type

7.2.3. Market size and forecast, by Application

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Type

7.2.5.1.3. Market size and forecast, by Application

7.2.5.1.4. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Type

7.2.5.2.3. Market size and forecast, by Application

7.2.5.2.4. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Type

7.2.5.3.3. Market size and forecast, by Application

7.2.5.3.4. Market size and forecast, by End User

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Type

7.3.3. Market size and forecast, by Application

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Type

7.3.5.1.3. Market size and forecast, by Application

7.3.5.1.4. Market size and forecast, by End User

7.3.5.2. France

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Type

7.3.5.2.3. Market size and forecast, by Application

7.3.5.2.4. Market size and forecast, by End User

7.3.5.3. UK

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Type

7.3.5.3.3. Market size and forecast, by Application

7.3.5.3.4. Market size and forecast, by End User

7.3.5.4. Italy

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Type

7.3.5.4.3. Market size and forecast, by Application

7.3.5.4.4. Market size and forecast, by End User

7.3.5.5. Spain

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Type

7.3.5.5.3. Market size and forecast, by Application

7.3.5.5.4. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Type

7.3.5.6.3. Market size and forecast, by Application

7.3.5.6.4. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Type

7.4.3. Market size and forecast, by Application

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Type

7.4.5.1.3. Market size and forecast, by Application

7.4.5.1.4. Market size and forecast, by End User

7.4.5.2. China

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Type

7.4.5.2.3. Market size and forecast, by Application

7.4.5.2.4. Market size and forecast, by End User

7.4.5.3. Australia

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Type

7.4.5.3.3. Market size and forecast, by Application

7.4.5.3.4. Market size and forecast, by End User

7.4.5.4. India

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Type

7.4.5.4.3. Market size and forecast, by Application

7.4.5.4.4. Market size and forecast, by End User

7.4.5.5. South Korea

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Type

7.4.5.5.3. Market size and forecast, by Application

7.4.5.5.4. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Type

7.4.5.6.3. Market size and forecast, by Application

7.4.5.6.4. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Type

7.5.3. Market size and forecast, by Application

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Type

7.5.5.1.3. Market size and forecast, by Application

7.5.5.1.4. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Type

7.5.5.2.3. Market size and forecast, by Application

7.5.5.2.4. Market size and forecast, by End User

7.5.5.3. South Africa

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Type

7.5.5.3.3. Market size and forecast, by Application

7.5.5.3.4. Market size and forecast, by End User

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Type

7.5.5.4.3. Market size and forecast, by Application

7.5.5.4.4. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2021

9.1. Trivitron Healthcare

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Key strategic moves and developments

9.2. Siemens AG

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.2.6. Business performance

9.2.7. Key strategic moves and developments

9.3. General Electric Company

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.3.7. Key strategic moves and developments

9.4. Koninklijke Philips N.V.

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.4.6. Business performance

9.4.7. Key strategic moves and developments

9.5. Ziehm Imaging GmbH

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.6. Nanjing Perlove Medical Equipment Co., Ltd.

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.7. Hologic, Inc.

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.7.6. Business performance

9.8. Canon Inc.

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.6. Business performance

9.8.7. Key strategic moves and developments

9.9. Shimadzu Corporation

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Business performance

9.10. FUJIFILM Holdings Corporation

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfolio

9.10.6. Business performance

9.10.7. Key strategic moves and development

LIST OF TABLES

TABLE 01. GLOBAL C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 02. C-ARMS MARKET FOR MOBILE C-ARMS, BY REGION, 2021-2031 ($MILLION)

TABLE 03. GLOBAL MOBILE C-ARMS C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 04. C-ARMS MARKET FOR FIXED C-ARMS, BY REGION, 2021-2031 ($MILLION)

TABLE 05. GLOBAL C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 06. C-ARMS MARKET FOR CARDIOLOGY, BY REGION, 2021-2031 ($MILLION)

TABLE 07. C-ARMS MARKET FOR GASTROENTEROLOGY, BY REGION, 2021-2031 ($MILLION)

TABLE 08. C-ARMS MARKET FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)

TABLE 09. C-ARMS MARKET FOR ORTHOPEDIC AND TRAUMA, BY REGION, 2021-2031 ($MILLION)

TABLE 10. C-ARMS MARKET FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)

TABLE 11. C-ARMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 12. GLOBAL C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 13. C-ARMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 14. C-ARMS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 15. C-ARMS MARKET FOR SPECIALTY CLINICS, BY REGION, 2021-2031 ($MILLION)

TABLE 16. C-ARMS MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 17. NORTH AMERICA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 18. NORTH AMERICA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 19. NORTH AMERICA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 20. NORTH AMERICA C-ARMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 21. U.S. C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 22. U.S. C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 23. U.S. C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 24. CANADA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 25. CANADA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 26. CANADA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 27. MEXICO C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 28. MEXICO C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 29. MEXICO C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 30. EUROPE C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 31. EUROPE C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 32. EUROPE C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 33. EUROPE C-ARMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 34. GERMANY C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 35. GERMANY C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 36. GERMANY C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 37. FRANCE C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 38. FRANCE C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 39. FRANCE C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 40. UK C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 41. UK C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 42. UK C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 43. ITALY C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 44. ITALY C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 45. ITALY C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 46. SPAIN C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 47. SPAIN C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 48. SPAIN C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 49. REST OF EUROPE C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 50. REST OF EUROPE C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 51. REST OF EUROPE C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. ASIA-PACIFIC C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 53. ASIA-PACIFIC C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 54. ASIA-PACIFIC C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 55. ASIA-PACIFIC C-ARMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 56. JAPAN C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 57. JAPAN C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 58. JAPAN C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 59. CHINA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 60. CHINA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 61. CHINA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 62. AUSTRALIA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 63. AUSTRALIA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 64. AUSTRALIA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 65. INDIA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 66. INDIA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 67. INDIA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 68. SOUTH KOREA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 69. SOUTH KOREA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 70. SOUTH KOREA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 71. REST OF ASIA-PACIFIC C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 73. REST OF ASIA-PACIFIC C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 74. LAMEA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 75. LAMEA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 76. LAMEA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 77. LAMEA C-ARMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 78. BRAZIL C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 79. BRAZIL C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 80. BRAZIL C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 81. SAUDI ARABIA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 82. SAUDI ARABIA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 83. SAUDI ARABIA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 84. SOUTH AFRICA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 85. SOUTH AFRICA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 86. SOUTH AFRICA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 87. REST OF LAMEA C-ARMS MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 88. REST OF LAMEA C-ARMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 89. REST OF LAMEA C-ARMS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 90. TRIVITRON HEALTHCARE: KEY EXECUTIVES

TABLE 91. TRIVITRON HEALTHCARE: COMPANY SNAPSHOT

TABLE 92. TRIVITRON HEALTHCARE: PRODUCT SEGMENTS

TABLE 93. TRIVITRON HEALTHCARE: PRODUCT PORTFOLIO

TABLE 94. TRIVITRON HEALTHCARE: KEY STRATERGIES

TABLE 95. SIEMENS AG: KEY EXECUTIVES

TABLE 96. SIEMENS AG: COMPANY SNAPSHOT

TABLE 97. SIEMENS AG: PRODUCT SEGMENTS

TABLE 98. SIEMENS AG: PRODUCT PORTFOLIO

TABLE 99. SIEMENS AG: KEY STRATERGIES

TABLE 100. GENERAL ELECTRIC COMPANY: KEY EXECUTIVES

TABLE 101. GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT

TABLE 102. GENERAL ELECTRIC COMPANY: PRODUCT SEGMENTS

TABLE 103. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO

TABLE 104. GENERAL ELECTRIC COMPANY: KEY STRATERGIES

TABLE 105. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES

TABLE 106. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 107. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS

TABLE 108. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 109. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES

TABLE 110. ZIEHM IMAGING GMBH: KEY EXECUTIVES

TABLE 111. ZIEHM IMAGING GMBH: COMPANY SNAPSHOT

TABLE 112. ZIEHM IMAGING GMBH: PRODUCT SEGMENTS

TABLE 113. ZIEHM IMAGING GMBH: PRODUCT PORTFOLIO

TABLE 114. NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: KEY EXECUTIVES

TABLE 115. NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: COMPANY SNAPSHOT

TABLE 116. NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: PRODUCT SEGMENTS

TABLE 117. NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: PRODUCT PORTFOLIO

TABLE 118. HOLOGIC, INC.: KEY EXECUTIVES

TABLE 119. HOLOGIC, INC.: COMPANY SNAPSHOT

TABLE 120. HOLOGIC, INC.: PRODUCT SEGMENTS

TABLE 121. HOLOGIC, INC.: PRODUCT PORTFOLIO

TABLE 122. CANON INC.: KEY EXECUTIVES

TABLE 123. CANON INC.: COMPANY SNAPSHOT

TABLE 124. CANON INC.: PRODUCT SEGMENTS

TABLE 125. CANON INC.: PRODUCT PORTFOLIO

TABLE 126. CANON INC.: KEY STRATERGIES

TABLE 127. SHIMADZU CORPORATION: KEY EXECUTIVES

TABLE 128. SHIMADZU CORPORATION: COMPANY SNAPSHOT

TABLE 129. SHIMADZU CORPORATION: PRODUCT SEGMENTS

TABLE 130. SHIMADZU CORPORATION: PRODUCT PORTFOLIO

TABLE 131. FUJIFILM HOLDINGS CORPORATION: KEY EXECUTIVES

TABLE 132. FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT

TABLE 133. FUJIFILM HOLDINGS CORPORATION: PRODUCT SEGMENTS

TABLE 134. FUJIFILM HOLDINGS CORPORATION: PRODUCT PORTFOLIO

TABLE 135. FUJIFILM HOLDINGS CORPORATION: KEY STRATERGIES LIST OF FIGURES

FIGURE 01. C-ARMS MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF C-ARMS MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN C-ARMS MARKET (2022-2031)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW BARGAINING POWER OF BUYERS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW THREAT OF NEW ENTRANTS

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALC-ARMS MARKET

FIGURE 10. C-ARMS MARKET, BY TYPE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR MOBILE C-ARMS, BY COUNTRY 2021-2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR FIXED C-ARMS, BY COUNTRY 2021-2031(%)

FIGURE 13. C-ARMS MARKET, BY APPLICATION, 2021(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR CARDIOLOGY, BY COUNTRY 2021-2031(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR GASTROENTEROLOGY, BY COUNTRY 2021-2031(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR NEUROLOGY, BY COUNTRY 2021-2031(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR ORTHOPEDIC AND TRAUMA, BY COUNTRY 2021-2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR ONCOLOGY, BY COUNTRY 2021-2031(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 20. C-ARMS MARKET, BY END USER, 2021(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY 2021-2031(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF C-ARMS MARKET FOR SPECIALTY CLINICS, BY COUNTRY 2021-2031(%)

FIGURE 24. C-ARMS MARKET BY REGION, 2021

FIGURE 25. U.S. C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 26. CANADA C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 27. MEXICO C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 28. GERMANY C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 29. FRANCE C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 30. UK C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 31. ITALY C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 32. SPAIN C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 33. REST OF EUROPE C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 34. JAPAN C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 35. CHINA C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 36. AUSTRALIA C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 37. INDIA C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 38. SOUTH KOREA C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 39. REST OF ASIA-PACIFIC C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 40. BRAZIL C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 41. SAUDI ARABIA C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 42. SOUTH AFRICA C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 43. REST OF LAMEA C-ARMS MARKET, 2021-2031 ($MILLION)

FIGURE 44. TOP WINNING STRATEGIES, BY YEAR

FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 48. COMPETITIVE DASHBOARD

FIGURE 49. COMPETITIVE HEATMAP: C-ARMS MARKET

FIGURE 50. TOP PLAYER POSITIONING, 2021

FIGURE 51. SIEMENS AG: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 52. SIEMENS AG: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 53. SIEMENS AG: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 54. GENERAL ELECTRIC COMPANY: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 55. GENERAL ELECTRIC COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 56. GENERAL ELECTRIC COMPANY: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 57. KONINKLIJKE PHILIPS N.V.: NET SALES, 2019-2021 ($MILLION)

FIGURE 58. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 59. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 60. HOLOGIC, INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 61. HOLOGIC, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 62. HOLOGIC, INC.: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 63. CANON INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 64. CANON INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 65. SHIMADZU CORPORATION: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 66. SHIMADZU CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 67. SHIMADZU CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 68. FUJIFILM HOLDINGS CORPORATION: NET SALES, 2019-2021 ($MILLION)

FIGURE 69. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 70. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE BY REGION, 2021 (%